Pulmonary hypertension in idiopathic pulmonary fibrosis does not influence six-minute walk distance: results from a retrospective study.
CONCLUSIONS: Our data suggested that 6MWD does not differ between IPF patients with or without PH. Thus, 6MWD should not be used as a surrogate endpoint in clinical study in patients affected by IPF and PH.
PMID: 25591141 [PubMed - in process]
Source: Sarcoidosis Vasculitis and Diffuse Lung Diseases - Category: Respiratory Medicine Tags: Sarcoidosis Vasc Diffuse Lung Dis Source Type: research
More News: Cardiac Catheterization | Cardiology | Clinical Trials | Heart | Hypertension | Pulmonary Function Testing | Pulmonary Hypertension | Respiratory Medicine | Sarcoidosis | Study | Vasculitis